96981 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans Hormones
Methods of delivering corticotroph-derived glycoprotein hormone
#902Human stanniocalcin-alpha
#903Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology
#904Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
#905Hybrid polypeptides having glucose lowering activity
#906Mucosal repair by TFF2 peptides
#907Methods for the production of peptide derivatives
#908Peg-physiologically active polypeptide homodimer complex having prolonged in vivo half-life and process for the preparation thereof
#909Albumin fusion proteins
#910Peptides directed for diagnosis and treatment of amyloid-associated disease
#911Hypoxia induced mitogenic factor
#912Peptide YY analogs
#913Method for improving recovery yield in protein purification with gel filtration chromatography
#914Albumin fusion proteins
#915Novel inhibin-related multiple antigenic peptide compositions that enhance production performance in avians
#916PYY agonists and use thereof
#917BMP-11 compositions
#918Expressing TGF-beta proteins in plant plastids
#919Neuropeptide-2 receptor (Y-2R) agonists and uses thereof
#920Compositions and methods for promoting angiogenesis
#921Erythrocyte differentiation factor, gene encoding same, and methods of use thereof
#922Counterion exchange process for peptides
#923Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
#924Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereof
#925Enrichment method for variant proteins with altered binding properties
#926TFF peptides
#927Proteins capable of binding to female sex hormones and process for producing the same
#928Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
#929Stabilized bioactive peptides and methods of identification, synthesis, and use
#930Method of preventing or treating liver disease
#931Pancreatic polypeptide family motifs and polypeptides comprising the same
#932Hybrid polypeptides with selectable properties
#933USE OF COMPOUNDS HAVING GIP ACTIVITY FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH ABNORMAL LOSS OF CELLS AND/OR FOR THE TREATMENT OF OBESITY
#934Antibodies to insulin/IGF/relaxin family polypeptides
#935Intermedin and its uses
#936Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
#937Method for determining MIF content
#938Adiponectin-knoucout nonhuman animal
#939Polypeptides and polynucleotides encoding same
#940Helicobacter system and uses thereof
#941Splice variants of peptide YY, neuropeptide Y, pancreatic peptide Y and Amylin, and uses thereof
#942Cortistatin: neuropeptides, compositions and methods
#943Peptides, DNAs, RNAs, and compounds for inhibiting or inducing adrenomedullin activity, and use of the same
#944Methods of identifying modulators of ligand binding to ChemerinR polypeptides
#945Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
#946Human spasmolytic polypeptide in glycosylated form
#947Biosynthetic polypeptides utilizing non-naturally encoded amino acids
#948Human spasmolytic polypeptide in glycosylated form
#949Monomeric protein of the TGF-β family
#950Analogs of gastric inhibitory polypeptide and their use of treatment for diabetes
#951Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
#952Ghrelin analogs
#953Methods and compositions for modulating and detecting activin dimer and dimer formation
#954Novel peptides having camp producing activity
#955Pluripotency determining factors and uses thereof
#956OGH fusion polypeptides and therapeutic uses thereof
#957Peptide hormones zalpha48 and zsig97
#958Cortistatin: neuropeptides, compositions and methods
#959Use of compounds having gip activity for the treatment of disorders associated with abnormal loss of cells and/or for the treatment of obesity
#960Methods of treatment with interferson and albumin fusion protein
#961Modified human interferon polypeptides and their uses
#962SGIP peptides
#963Human stanniocalcin-alpha
#964Methods for detecting Corpuscles of Stannius protein stanniocalcin
#965Contulakin-G, analogs thereof and uses therefor
#966Albumin fusion proteins comprising GLP-1 polypeptides
#967Trefoil factor 3 (TFF3) as a target for anti-cancer therapy
#968hC1Q/TNF7 and uses thereof
#969Therapeutic method
#970Polypeptides, their production and use
#971Human growth hormone modified at position 35
#972Metallopeptide compositions for treatment of sexual dysfunction
#973Monoclonal antibodies that bind Chemerin polypeptide
#974Peptides and polypeptides derived from the submaxillary gland of the rat, corresponding polyclonal and monoclonal antibodies, corresponding hybridomas and uses of these products for diagnosis, for detection or therapeutic purposes
#975FGF variants and methods for use thereof
#976Inducing sterility in fish by disrupting the development of the GnRH system
#977Type1 diabetes diagnostics and therapeutics
#978Antibodies to motilin homologs
#979Novel glycoproteins and methods of use thereof
#980Method and compositions for evaluating risk of developing type 2 diabetes in people of chinese descent
#981Novel glycoproteins and methods of use thereof
#982Chemically modified metabolites of regulatory peptides and methods of producing and using same
#983Compositions, methods, and kits relating to resistin-like molecules
#984Amplification and overexpression of oncogenes
#985Stable analogs of peptide and polypeptide therapeutics
#986Zsig33-like peptides and polynucleotides
#987Antibodies to PRO1410
#988Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use
#989Methods and compositions for selective modulation of vascularization
#990Process for preparing purified active monomer of bone-derived factor
#991Mammalian glycoprotein hormone-1
#992Selective melanin-concentrating hormone type-1 receptor agonists
#993Polypeptide hormone phosphatonin
#994Secreted proteins and polynucleotides encoding them